Suchergebnisse - "Byrd, John"

PubPharm (1.294)

31

Correction : HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide

enthalten in: Oncotarget | 2023

von Canella, A. | Nieves, H. | Sborov, D. | +15

32

Methods of treating and preventing graft versus host disease

enthalten in: Europäisches Patentamt | 2023

von MIKLOS DAVID | BYRD JOHN C | DUBOVSKY JASON A | +2

33

Methods of treating and preventing graft versus host disease

enthalten in: Europäisches Patentamt | 2023

von MIKLOS DAVID | BYRD JOHN C | DUBOVSKY JASON A | +2

34

Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial

enthalten in: Blood | 2023

von Seymour, J. | Byrd, J. | Ghia, P. | +15

CommentIn: Blood. 2023 Aug 24;142(8):679-680. - PMID 37616021

35

Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia : Alliance for Clinical Trials in Oncology study

enthalten in: Blood advances | 2023

von Bhatnagar, B. | Kohlschmidt, J. | Orwick, S. | +14

36

B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Woyach, J. | Ghia, P. | Byrd, J. | +10

37

Mass Cytometry as a Tool for Investigating Senescence in Multiple Model Systems

enthalten in: Cells | 2023

von Abdul-Aziz, A. | Devine, R. | Lyberger, J. | +7

38

Association of social deprivation with survival in younger adult patients with AML : an Alliance study

enthalten in: Blood advances | 2023

von Rebechi, M. | Kohlschmidt, J. | Mrózek, K. | +17

39

Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype : A phase 2 substudy of the Beat AML Master Trial

enthalten in: Cancer | 2023

von Duong, V. | Ruppert, A. | Mims, A. | +34

40

Correction : Evaluation of bleeding events in patients receiving acalabrutinib therapy

enthalten in: Leukemia | 2023

von Kumar, P. | Wiczer, T. | Rosen, L. | +10

ErratumFor: Leukemia. 2023 Jul;37(7):1554-1557. - PMID 36932166